comparemela.com

Latest Breaking News On - குழாய் நெகிழ்வு - Page 1 : comparemela.com

Pipeline Flex Endovascular Flow Diverters Under Recall

Pipeline Flex Endovascular Flow Diverters Under Recall
medpagetoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medpagetoday.com Daily Mail and Mail on Sunday newspapers.

Global Interventional Oncology Devices Market 2021-2030: Focus on Thermal Tumor Ablation, Non-thermal Tumor Ablation, TACE, SIRT, TAE, Bland Embolization

Global Interventional Oncology Devices Market 2021-2030: Focus on Thermal Tumor Ablation, Non-thermal Tumor Ablation, TACE, SIRT, TAE, Bland Embolization
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Brain Aneurysm Treatment Market is expected to reach US$ 6,222 47 Mn with a CAGR of 14 1% from 2020-2027

Brain Aneurysm Treatment Market is expected to reach US$ 6,222 47 Mn with a CAGR of 14 1% from 2020-2027
texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.

Brain Aneurysm Treatment Market is expected to reach US$ 6,222 47 Mn with a CAGR of 14 1% from 2020-2027

Brain Aneurysm Treatment Market is expected to reach US$ 6,222 47 Mn with a CAGR of 14 1% from 2020-2027
sandiegosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegosun.com Daily Mail and Mail on Sunday newspapers.

Medtronic Receives U S FDA Approval for Pipeline™ Flex Embolization Device with Shield Technology™

Share this article Share this article First Patient Receives New Shield Surface Modification, An Advance in Flow Diversion Therapy, at NYU Langone Health DUBLIN, April 21, 2021 /PRNewswire/ Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received approval from the United States Food and Drug Administration (FDA) for Pipeline™ Flex Embolization Device with Shield Technology™. Medtronic developed Shield Technology, a proprietary breakthrough in biomaterial science, to advance flow diversion therapy by introducing the first surface-modified implant device which demonstrates reduction in material thrombogenicity, a reduction in the tendency of the surface treatment material to create clots. NYU Langone Health in New York City performed the first patient procedure in the nation with the new device.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.